In this op-ed, Kenneth Wener, MD (Infectious Diseases, LHMC) and Mary LaSalvia, MD (Infectious Diseases, BIDMC) join infectious disease leaders across Boston in encouraging local residents to follow Governor Baker’s newly updated COVID-19 guidelines.

They balance the public health benefits of keeping the population safe — and in school — with the need to maintain a strong economy to support all the residents of our state.

A team of researchers, including John Torous, MD (Digital Psychiatry, BIDMC), used machine learning to analyze the text of more than 800,000 Reddit posts and identify changes in the tone and content of language that people used as the first wave of the pandemic progressed.

AI and Reddit are helping us track COVID-19's impact on mental health

Healthcare Heroes

BIDMC honors the incredible efforts of our ...

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses the recently released interim analysis of Pfizer’s COVID-19 vaccine candidate.

It may be a ‘triumph of science,’ but still a long way to go

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses delays faced in getting routing items while working to develop a COVID-19 vaccine.

Pharma companies have had to adapt to a rare impediment—having to carry out their work on the disease while it’s all around them

Leo Newhouse, MSW, LICSW (Social Work, BIDMC) shares his experience with sudden loss of smell due to COVID-19 and discusses the importance the five senses bring to everyday life.

No specific treatment or medication exists to treat anosmia. And yet, a patient's brain can be trained to accelerate the recovery of the lost sense of smell.

A team of researchers, including John Torous, MD (Digital Psychiatry, BIDMC), used machine learning to analyze the text of more than 800,000 Reddit posts and identify changes in the tone and content of language that people used as the first wave of the Covid-19 pandemic progressed.

Textual analysis of social media posts finds users’ anxiety and suicide-risk levels are rising, among other negative trends.

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) and other collaborators recently published a study showing that a SARS-CoV-2 vaccine protected against weight loss and pneumonia in Syrian hamsters.

Researchers turn to familiar model animals, along with some fresh strategies, to develop countermeasures against SARS-CoV-2 and investigate the biology of infection.

Nathan Shapiro, MD (Emergency Medicine, BIDMC) discusses a clinical trial to test a repurposed antiviral AIDS drug for at-home treatment during the first days of COVID-19 symptoms in hopes of slowing the virus early and heading off hospitalization, intensive care, and death.

A new research is hoping to nip a COVID-19 infection in the bud before it progresses. (WJAR)